284 related articles for article (PubMed ID: 28523576)
1. Proteomic Analysis of Serum Amyloid A as a Potential Marker in Intestinal Behçet's Disease.
Lee HJ; Kim JH; Kim SW; Joo HA; Lee HW; Kim YS; Park SJ; Hong SP; Kim TI; Kim WH; Kim YH; Cheon JH
Dig Dis Sci; 2017 Aug; 62(8):1953-1962. PubMed ID: 28523576
[TBL] [Abstract][Full Text] [Related]
2. MALDI-TOF/TOF-MS reveals elevated serum haptoglobin and amyloid A in Behcet's disease.
Mao L; Dong H; Yang P; Zhou H; Huang X; Lin X; Kijlstra A
J Proteome Res; 2008 Oct; 7(10):4500-7. PubMed ID: 18754684
[TBL] [Abstract][Full Text] [Related]
3. Expression of a soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) correlates with clinical disease activity in intestinal Behcet's disease.
Jung YS; Kim SW; Yoon JY; Lee JH; Jeon SM; Hong SP; Kim TI; Kim WH; Cheon JH
Inflamm Bowel Dis; 2011 Oct; 17(10):2130-7. PubMed ID: 21910175
[TBL] [Abstract][Full Text] [Related]
4. Behcet's disease with active uveitis: detection of serum protein biomarkers using MALDI-TOF-MS.
Wang X; Zhang MF; Xie J; Li ZL; Wang P
Anat Rec (Hoboken); 2012 Jul; 295(7):1168-73. PubMed ID: 22641412
[TBL] [Abstract][Full Text] [Related]
5. Proteomics-based functional studies reveal that galectin-3 plays a protective role in the pathogenesis of intestinal Behçet's disease.
Lee HJ; Kim JH; Hong S; Hwang I; Park SJ; Kim TI; Kim WH; Yu JW; Kim SW; Cheon JH
Sci Rep; 2019 Aug; 9(1):11716. PubMed ID: 31406212
[TBL] [Abstract][Full Text] [Related]
6. Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease.
Lucherini OM; Lopalco G; Cantarini L; Emmi G; Lopalco A; Venerito V; Vitale A; Iannone F
Immunol Lett; 2018 Sep; 201():38-44. PubMed ID: 30385329
[TBL] [Abstract][Full Text] [Related]
7. Serum amyloid A as a prognostic marker in melanoma identified by proteomic profiling.
Findeisen P; Zapatka M; Peccerella T; Matzk H; Neumaier M; Schadendorf D; Ugurel S
J Clin Oncol; 2009 May; 27(13):2199-208. PubMed ID: 19307507
[TBL] [Abstract][Full Text] [Related]
8. Serum immunoglobulin D levels in patients with Behçet's disease according to different clinical manifestations.
Lucherini OM; Vitale A; Orlando I; Sota J; Fabiani C; Franceschini R; Simpatico A; Frediani B; Galeazzi M; Tosi GM; Cantarini L
Clin Exp Rheumatol; 2018; 36(6 Suppl 115):110-115. PubMed ID: 30582507
[TBL] [Abstract][Full Text] [Related]
9. Putative Role of Serum Amyloid-A and Proinflammatory Cytokines as Biomarkers for Behcet's Disease.
Lopalco G; Lucherini OM; Vitale A; Talarico R; Lopalco A; Galeazzi M; Lapadula G; Cantarini L; Iannone F
Medicine (Baltimore); 2015 Oct; 94(42):e1858. PubMed ID: 26496336
[TBL] [Abstract][Full Text] [Related]
10. Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behçet's disease.
Lee KH; Chung HS; Kim HS; Oh SH; Ha MK; Baik JH; Lee S; Bang D
Arthritis Rheum; 2003 Jul; 48(7):2025-35. PubMed ID: 12847697
[TBL] [Abstract][Full Text] [Related]
11. Correlation of Serum Amyloid-A Levels, Clinical Manifestations, Treatment, and Disease Activity in Patients with Behçet's Disease.
Sota J; Vitale A; Rigante D; Orlando I; Lucherini OM; Simpatico A; Lopalco G; Franceschini R; Galeazzi M; Frediani B; Fabiani C; Tosi GM; Cantarini L
Isr Med Assoc J; 2018 Aug; 20(8):517-521. PubMed ID: 30084580
[TBL] [Abstract][Full Text] [Related]
12. Increased serum interleukin-32 levels in patients with Behçet's disease.
Ha YJ; Park JS; Kang MI; Lee SK; Park YB; Lee SW
Int J Rheum Dis; 2018 Dec; 21(12):2167-2174. PubMed ID: 28378461
[TBL] [Abstract][Full Text] [Related]
13. Serum IL-33 levels and skin mRNA expression in Behçet's disease.
Hamzaoui K; Kaabachi W; Fazaa B; Zakraoui L; Mili-Boussen I; Haj-Sassi F
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):6-14. PubMed ID: 23464866
[TBL] [Abstract][Full Text] [Related]
14. Potential metabolomic biomarkers for reliable diagnosis of Behcet's disease using gas chromatography/ time-of-flight-mass spectrometry.
Ahn JK; Kim J; Hwang J; Song J; Kim KH; Cha HS
Joint Bone Spine; 2018 May; 85(3):337-343. PubMed ID: 28549946
[TBL] [Abstract][Full Text] [Related]
15. Preliminary characterizations of a serum biomarker for sarcoidosis by comparative proteomic approach with tandem-mass spectrometry in ethnic Han Chinese patients.
Zhang Y; Chen X; Hu Y; Du S; Shen L; He Y; Zhang Y; Zhang X; Li H; Yung RC
Respir Res; 2013 Feb; 14(1):18. PubMed ID: 23399022
[TBL] [Abstract][Full Text] [Related]
16. [Effect of tripterygium glycosides on serum interleukin-1beta, interleukin-2, tumor necrosis factor alpha, and interferon-gamma levels in patients with Behcet's disease].
Song Q; Lu JZ; Li J
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Jun; 30(6):598-600. PubMed ID: 20815274
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis-based discovery of a novel biomarker that differentiates intestinal Behçet's disease from Crohn's disease.
Park J; Jeong D; Chung YW; Han S; Kim DH; Yu J; Cheon JH; Ryu JH
Sci Rep; 2021 May; 11(1):11019. PubMed ID: 34040049
[TBL] [Abstract][Full Text] [Related]
18. Proteomic surveillance of autoimmunity in Behcet's disease with uveitis: selenium binding protein is a novel autoantigen in Behcet's disease.
Okunuki Y; Usui Y; Takeuchi M; Kezuka T; Hattori T; Masuko K; Nakamura H; Yudoh K; Usui M; Nishioka K; Kato T
Exp Eye Res; 2007 May; 84(5):823-31. PubMed ID: 17343851
[TBL] [Abstract][Full Text] [Related]
19. Correlation between soluble triggering receptor expressed on myeloid cells-1 and endoscopic activity in intestinal Behçet's disease.
Lee HJ; Shin HS; Jang HW; Kim SW; Park SJ; Hong SP; Kim TI; Kim WH; Cheon JH
Yonsei Med J; 2014 Jul; 55(4):960-6. PubMed ID: 24954324
[TBL] [Abstract][Full Text] [Related]
20. Circulating immune complexome analysis identified anti-tubulin-α-1c as an inflammation associated autoantibody with promising diagnostic value for Behcet's Disease.
Cheng Y; Zhao X; Chen Y; Li Y; Jia R; Zhu L; Huang C; Sun X; Deng H; Li Z
PLoS One; 2018; 13(6):e0199047. PubMed ID: 29902281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
